Dose-dependent effects of medroxyprogesterone acetate on the hepatic drug-metabolizing enzyme system in rats
- 1 April 1980
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 29 (8) , 1155-1159
- https://doi.org/10.1016/0006-2952(80)90411-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancerPublished by Elsevier ,1979
- Metabolism of diphenyloxazole (PPO) by mouse liver microsomesLife Sciences, 1975
- Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal CancerBritish Journal of Cancer, 1971
- Progestogen treatment of recurrent endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1971
- Effects of depo-medroxyprogesterone acetate as a contraceptive agentAmerican Journal of Obstetrics and Gynecology, 1971
- Human Hepatic Testosterone A-Ring Reductase Activity: Effect of Medroxyprogesterone AcetateJournal of Clinical Endocrinology & Metabolism, 1971
- Effect of Medroxyprogesterone Acetate (Provera) on the Metabolism and Biological Activity of TestosteroneJournal of Clinical Endocrinology & Metabolism, 1970
- Effect of contraceptive agents on drug metabolismEuropean Journal of Pharmacology, 1969
- Substrate-inducible Microsomal Aryl Hydroxylase in Mammalian Cell CulturePublished by Elsevier ,1968
- Medroxyprogesterone Acetate in the Treatment of Constitutional Sexual PrecocityJournal of Clinical Endocrinology & Metabolism, 1962